Exploration in the mechanism of rhubarb for the treatment of hyperviscosity syndrome based on network pharmacology.

Journal of Ethnopharmacology
Dan GaoMing Niu

Abstract

Hyperviscosity syndrome (HVS) is a major risk factor for thrombotic diseases. Rhubarb, well-known as a traditional Chinese medicine, exhibits multiple pharmacological activities, especially for promoting blood circulation to remove blood stasis (PBRB), which has been become a functional health food for decreasing the risk of cardiovascular diseases. However, due to the complexity of rhubarb components, it is still difficult to clarify the specific targets of effective substances in PBRB, and the pharmacodynamic mechanism needs to be further probed. The "compound-target-cell-disease" network analysis was initially used to predict potential targets and bioactive compounds. The effect of rhubarb for the treatment of HVS was examined by histopathology and biochemical assays based on the HVS rat model. Through the "compound-target-cell-disease" network analysis, eight potential therapeutic targets were eventually screened out, and platelets were predicted as the main effector cells of rhubarb in PBRB. Among targets coagulation factor II (prothrombin, F2) and fibrinogen gamma chain (FGG) were closely related to platelets, and five compounds associated with F2 and FGG were predicted including emodin-8-O-beta-D-glucopyranoside (Emo), p...Continue Reading

References

Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·D H FarrellE W Davie
Jul 23, 1970·The New England Journal of Medicine·R Wells
Sep 18, 1999·Archives of Pharmacal Research·S K KoW K Whang
Sep 10, 2003·The Journal of Perinatal & Neonatal Nursing·Elizabeth A Gordon
Nov 25, 2003·Seminars in Thrombosis and Hemostasis·Michael W Rampling
Apr 20, 2005·Journal of the American College of Cardiology·Shinji YokoyamaTsutomu Imaizumi
Jul 13, 2005·European Journal of Pediatrics·Weihua ZhuHenning Neubauer
Oct 26, 2005·Circulation·Jane E Freedman
Dec 19, 2006·Cardiology in Review·Andrew Paul DeFilippisJames R Eckman
Jan 30, 2009·Journal of Gastroenterology and Hepatology·Yun-Lian LinYi-Tsau Huang
Aug 24, 2012·Seminars in Thrombosis and Hemostasis·Oguz K Baskurt, Herbert J Meiselman
Aug 28, 2014·Drug Development Research·Da Cheng Hao, Pei Gen Xiao
Mar 24, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Dan GaoJia-Bo Wang
Feb 25, 2018·Intensive Care Medicine·Guillaume DumasEric Maury
Apr 18, 2018·Clinical Hemorheology and Microcirculation·Dong Woo ShinHyun Kyung Kim
Aug 17, 2018·BioMed Research International·Xiangping LinTao Tang
Nov 1, 2014·Chinese Herbal Medicines·Yin XiongXiao-He Xiao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

© 2022 Meta ULC. All rights reserved